InvestorsHub Logo
Followers 18
Posts 907
Boards Moderated 0
Alias Born 09/28/2014

Re: None

Tuesday, 06/27/2023 11:29:12 AM

Tuesday, June 27, 2023 11:29:12 AM

Post# of 708740
I am asking the “more knowledgeable posters” on this board to review the linked post (6/26/2023) I found on the UK’s ATTC site and ascertain if this might have any relevance to NWBO as they await approval.

“Advanced Therapy Medicinal Products (ATMPs) aim to restore health following one time treatment. However, constraints that impede delivery have been identified across several parts of the pathway from manufacturer through to delivery sites.”


“Reviewing the Impact of Constraints on the Cost-effectiveness of Cell and Gene Therapies: A Systematic Review”

https://www.theattcnetwork.co.uk/imatch/reviewing-the-impact-of-constraints-on-the-cost-effectiveness-of-cell-and-gene-therapies-a-systematic-review
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News